TAS2R39
geneOn this page
Summary
TAS2R39 (taste 2 receptor member 39, HGNC:18886) is a protein-coding gene on chromosome 7q34, encoding Taste receptor type 2 member 39 (P59534). Receptor that may play a role in the perception of bitterness and is gustducin-linked.
The protein encoded by this gene is a bitter taste receptor that detects green tea catechins, soy isoflavones, and theaflavins. The encoded protein is gustducin-linked and may activate alpha gustducin. This gene is intronless.
Source: NCBI Gene 259285 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 51 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_176881
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18886 |
| Approved symbol | TAS2R39 |
| Name | taste 2 receptor member 39 |
| Location | 7q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000236398 |
| Ensembl biotype | protein_coding |
| Entrez | 259285 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000446620
RefSeq mRNA: 1 — MANE Select: NM_176881
NM_176881
CCDS: CCDS47729
Canonical transcript exons
ENST00000446620 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001762990 | 143183419 | 143184435 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 85.83.
Top tissues by expression
228 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.83 | gold quality |
| corpus callosum | UBERON:0002336 | 67.09 | gold quality |
| upper leg skin | UBERON:0004262 | 51.76 | silver quality |
| medial globus pallidus | UBERON:0002477 | 50.75 | gold quality |
| globus pallidus | UBERON:0001875 | 48.40 | gold quality |
| cardia of stomach | UBERON:0001162 | 45.86 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| sural nerve | UBERON:0015488 | 43.07 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 41.81 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| ventral tegmental area | UBERON:0002691 | 41.05 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 40.65 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- these results suggest the participation of hTAS2R39 in the detection of catechins in humans. (PMID:21272567)
- Human bitter taste receptors hTAS2R8 and hTAS2R39 display differential functions to recognize bitter peptides. (PMID:21670512)
- TAS2R14 and TAS2R39 were activated by isoflavones and other isoflavonoids. (PMID:21942422)
- hTAS2R39 is the primary receptor for the bitterness of theaflavins (PMID:25273142)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tas2r200.2 | ENSDARG00000074066 |
| danio_rerio | tas2r200.1 | ENSDARG00000079880 |
| mus_musculus | Tas2r139 | ENSMUSG00000047102 |
| rattus_norvegicus | Tas2r139 | ENSRNOG00000028135 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 39 — P59534 (reviewed: P59534)
Alternative names: Taste receptor type 2 member 57
All UniProt accessions (1): P59534
UniProt curated annotations — full annotation on UniProt →
Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.
Subcellular location. Membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_795362* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59534-F1 | 81.44 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 185, 194
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 28 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, FOXO1_01, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP, RTAAACA_FREAC2_01
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), bitter taste receptor activity (GO:0033038)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of chemical stimulus involved in sensory perception of taste | 1 |
| sensory perception of bitter taste | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
352 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R39 | TAS1R2 | Q8TE23 | 675 |
| TAS2R39 | PKD2L1 | Q9P0L9 | 578 |
| TAS2R39 | TAS1R3 | Q7RTX0 | 541 |
| TAS2R39 | GNAT3 | A8MTJ3 | 540 |
| TAS2R39 | TAS1R1 | Q7RTX1 | 524 |
| TAS2R39 | PKD1L3 | Q7Z443 | 519 |
| TAS2R39 | OR3A3 | P47888 | 507 |
| TAS2R39 | GPRC6A | Q5T6X5 | 506 |
| TAS2R39 | TAS2R1 | Q9NYW7 | 503 |
| TAS2R39 | PLCB2 | Q00722 | 420 |
| TAS2R39 | CASR | P41180 | 417 |
| TAS2R39 | TRPM5 | Q9NZQ8 | 415 |
| TAS2R39 | SCNN1B | P51168 | 412 |
| TAS2R39 | HCN4 | Q9Y3Q4 | 391 |
| TAS2R39 | OR1E2 | P47887 | 376 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TAS2R39 | PTBP3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TAS2R39 | rep | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (2): TAS2R39 (Proximity Label-MS), PTBP3 (Affinity Capture-MS)
ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8
Diamond homologs: P59530, P59532, P59534, P59536, P59537, P59539, P59540, P59541, P59551, Q2AB83, Q50KZ9, Q5Y4Y8, Q5Y4Z0, Q5Y4Z8, Q5Y500, Q645S2, Q645S5, Q645T0, Q645T4, Q645T7, Q645U1, Q645U2, Q645U4, Q645U6, Q645U7, Q645U8, Q645V1, Q645V3, Q645V8, Q645V9, Q645Y3, Q645Y4, Q645Y5, Q645Y7, Q645Y8, Q645Z0, Q645Z5, Q645Z7, Q646A2, Q646A3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
227 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:143184272:T:G | acceptor_gain | 0.8300 |
| 7:143184243:A:AG | acceptor_gain | 0.7900 |
| 7:143184244:G:GG | acceptor_gain | 0.7900 |
| 7:143184146:G:GT | donor_gain | 0.7600 |
| 7:143184286:A:AG | acceptor_gain | 0.7600 |
| 7:143184287:G:GG | acceptor_gain | 0.7600 |
| 7:143184243:AGTT:A | acceptor_gain | 0.7100 |
| 7:143184244:GTTG:G | acceptor_gain | 0.7100 |
| 7:143184238:A:AG | acceptor_gain | 0.6900 |
| 7:143184287:GTCT:G | acceptor_gain | 0.6700 |
| 7:143184244:GTT:G | acceptor_gain | 0.6500 |
| 7:143183495:A:T | donor_gain | 0.6300 |
| 7:143184231:C:G | acceptor_gain | 0.6200 |
| 7:143184238:AAT:A | acceptor_gain | 0.6100 |
| 7:143184244:GT:G | acceptor_gain | 0.6000 |
| 7:143184086:T:G | acceptor_gain | 0.5800 |
| 7:143184181:G:GT | donor_gain | 0.5800 |
| 7:143184240:T:TA | acceptor_gain | 0.5600 |
| 7:143184099:A:AG | acceptor_gain | 0.5500 |
| 7:143184100:G:GG | acceptor_gain | 0.5500 |
| 7:143184100:GCC:G | acceptor_gain | 0.5400 |
| 7:143184124:A:AC | acceptor_gain | 0.5400 |
| 7:143184232:A:AG | acceptor_gain | 0.5400 |
| 7:143184271:AT:A | acceptor_gain | 0.5400 |
| 7:143184302:TGTGC:T | acceptor_gain | 0.5300 |
| 7:143184062:T:A | acceptor_gain | 0.5200 |
| 7:143184240:TGCA:T | acceptor_loss | 0.5200 |
| 7:143184241:GCAG:G | acceptor_loss | 0.5200 |
| 7:143184243:AGTTG:A | acceptor_loss | 0.5200 |
| 7:143184271:A:AG | acceptor_gain | 0.5200 |
AlphaMissense
2251 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:143183680:A:C | S88R | 0.921 |
| 7:143183682:C:A | S88R | 0.921 |
| 7:143183682:C:G | S88R | 0.921 |
| 7:143183656:A:C | S80R | 0.892 |
| 7:143183658:T:A | S80R | 0.892 |
| 7:143183658:T:G | S80R | 0.892 |
| 7:143183788:A:C | S124R | 0.873 |
| 7:143183790:C:A | S124R | 0.873 |
| 7:143183790:C:G | S124R | 0.873 |
| 7:143183935:A:C | S173R | 0.867 |
| 7:143183937:C:A | S173R | 0.867 |
| 7:143183937:C:G | S173R | 0.867 |
| 7:143183812:A:C | S132R | 0.850 |
| 7:143183814:T:A | S132R | 0.850 |
| 7:143183814:T:G | S132R | 0.850 |
| 7:143184088:T:C | F224L | 0.846 |
| 7:143184090:C:A | F224L | 0.846 |
| 7:143184090:C:G | F224L | 0.846 |
| 7:143183764:A:C | S116R | 0.845 |
| 7:143183766:T:A | S116R | 0.845 |
| 7:143183766:T:G | S116R | 0.845 |
| 7:143183578:T:C | F54L | 0.810 |
| 7:143183580:C:A | F54L | 0.810 |
| 7:143183580:C:G | F54L | 0.810 |
| 7:143184217:T:C | F267L | 0.810 |
| 7:143184219:T:A | F267L | 0.810 |
| 7:143184219:T:G | F267L | 0.810 |
| 7:143183857:T:C | F147L | 0.797 |
| 7:143183859:C:A | F147L | 0.797 |
| 7:143183859:C:G | F147L | 0.797 |
dbSNP variants (sampled 300 via entrez): RS1000175649 (7:143184610 G>A), RS1000249120 (7:143184242 C>A,G), RS1000510219 (7:143183056 T>C), RS1001951185 (7:143183765 G>A,C), RS1002364583 (7:143181514 A>G), RS1004026018 (7:143183170 G>A), RS1005265097 (7:143182131 G>A), RS1006299708 (7:143182084 A>G), RS1006541173 (7:143182174 A>C,G), RS1007818278 (7:143182464 T>C), RS1008137078 (7:143184164 C>T), RS1008222812 (7:143182792 C>T), RS1010698980 (7:143184649 C>T), RS1011510501 (7:143184593 T>C), RS1012226961 (7:143183201 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523249 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
Most potent curated ligand interactions (14 total), top 14:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| theaflavin-3′-O-gallate | Agonist | 6.17 | pEC50 |
| theaflavin | Agonist | 5.55 | pEC50 |
| luteolin | Agonist | 5.14 | pEC50 |
| epicatechin gallate | Agonist | 4.67 | pEC50 |
| 6-Methylflavone | Antagonist | 4.66 | pIC50 |
| naringenin | Agonist | 4.48 | pEC50 |
| scutellarein | Agonist | 4.39 | pEC50 |
| datiscetin | Agonist | 4.38 | pEC50 |
| phloretin | Agonist | 4.38 | pEC50 |
| genistein | Agonist | 4.31 | pEC50 |
| (±)-Equol | Agonist | 4.25 | pEC50 |
| epigallocatechin | Agonist | 3.4 | pEC50 |
| (-)-Epicatechin | Agonist | 3.38 | pEC50 |
| vanillin | Agonist | 3.06 | pEC50 |
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
ChEMBL screening assays
8 unique, capped per target: 8 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4346434 | Functional | Antagonist activity at recombinant human TAS2R39 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of ranitidine-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dye | Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Tenofovir Alafenamide